AzTrials
AzTrials

End Stage Renal DiseasePeridialysisNCT02488200

Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis

An observational study of End Stage Renal Disease, run by Herlev Hospital at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered. 1. What factors influence unplanned DI? 2. Read more about this study

Who is it for?
Ages 1 month to 95 years
Conditions the study is for
End Stage Renal Disease
How many people
1,400 participants
Where
1 siteDenmark
Study dates
Jan 2015to Jan 2020
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 95 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with Chronic Kidney Disease Stage 5 WHO start dialysis therapy for ESRD

Who may be able to join

  • All patients starting maintenance dialysis therapies at the participating centers

Who cannot join

  • Africans

Trial locations and contacts

1 site in 1 country.

James G Heaf, MD DMSc contact

+4535125361

heaf@dadlnet.dk

Denmark1 site, 1 recruiting
  • Herlev Hospital

    Herlev, 2730

    James G Heaf, MD DMSc, +4535125361, heaf@dadlnet.dk

    Recruiting

Other trials in Denmark

About this study

The present study plans to delineate the clinical, biochemical, sociological and psychological factors. involved in dialysis preparation, and their impact on dialysis initiation (DI), modality choice and prognosis. In particular the following questions are to be answered.

  1. What factors influence unplanned DI?
  2. What factors influence choice of dialysis modality?
  3. What factors influence choice of dialysis access?
  4. Why do physicians start dialysis?
  5. What factors in the predialytic period and its immediate aftermath (the "peridialytic" period) influence prognosis?
Read the detailed description

Patients All patients starting active end stage renal disease (ESRD) treatment at the participating centres and their satellite centres.

No. Patients: 1000.

  1. Patients who have received their recent predialysis care at another centre can be included if the previous centre's notes are available, otherwise not.
  2. Patients receiving a preemptive transplant are included, even if the transplant is performed at another centre. A patient questionnaire is not required for these patients.
  3. Africans are excluded (inaccurate estimated glomerular filtration rate (eGFR) calculation) Each patient is allocated a local identity number (1,2,3….). The local author keeps a registry of the true patient identity of each identity number for follow-up purposes. This registry is not to be used in any communication outside the centre.

Comment: Most patients have known chronic uremia at dialysis start. In a few cases, it is unknown whether the uremia is acute or chronic. There are two main groups:

  1. Acute uremia of unknown origin. Doctors should fill the questionnaire in Table 2, which can be discarded if the patient recovers renal function within three months.
  2. Acute kidney injury (AKI). Most of these patients will recover within three months, so the questionnaire can wait, and be filled in retrospectively for the few remaining patients.

Methods

  1. Each participating centre fills a Centre Questionnaire, see Table 1.
  2. All prescribing doctors fill in a voluntary Physician Questionnaire, see Table 4.
  3. The doctor prescribing the first dialysis fills in a Motivation Questionnaire, see Table 2.
  4. The local coordinator fills in a Patient Notes Review
  5. Birthday
  6. Sex
  7. Height and weight
  8. Renal diagnosis
  9. Comorbidity
  10. Date and creatinine at referral to nephrology dept.
  11. Date and creatinine 6 months before dialysis start
  12. Date and creatinine 3 months before dialysis start
  13. Date and creatinine at start of dialysis information/choice
  14. Date and creatinine at access prescription. Date and creatinine at access creation. If there are several attempts at access creation, the last attempt is registered. For unplanned dialysis start, this is often the same date as dialysis start.
  15. Date of dialysis start
  16. Following values before first dialysis: B-hemoglobin, p- creatinine, urea, potassium, calcium, phosphate, bicarbonate, albumin
  17. Initial dialysis modality (centre hemodialysis (HD)/Home HD/continuous ambulatory peritoneal dialysis (CAPD)/ automated peritoneal dialysis (APD))
  18. Type of start (Planned/unplanned)
  19. Reason for unplanned start (primary and (if appropriate) secondary).
  20. For hemodialysis patient (HD) patients, initial access (areteriovenous fisula (AVF)/arteriovenous graft (AVG) /tunneled central venous catheter (CVC)/temporary CVC)
  21. Modality after 3 months (Center HD/Home HD/CAPD/APD/regained function/Transplanted/Dead)
  22. Is the patient alive after 3 months Yes/No. If "No" Date of death.
  23. Is the patient alive after 6 months Yes/No.
  24. If "No" Date of death.Is the patient alive after 12 months Yes/No. If "No" Date of death.
  25. Was the patient transplanted after inclusion? If so, when?

Responsibilities National coordinators are responsible for translation of protocol to local language, and compliance with any necessary national regulatory requirements (data protection agency, ethical committee?) Local representatives: local coordination and follow-up. Patient notes review. Additional secretarial assistance, paid or unpaid, is permitted.

Definitions

ESRD

A patient has ESRD if any of the following:

  1. He receives a transplant
  2. The doctor "believes" that he has ESRD at first dialysis
  3. He has received >90 days dialysis
  4. If the doctor is in doubt whether the patient has acute or chronic renal failure, the patient is registered as soon as there is no doubt that the patient has ESRD For 3 \& 4, registration is performed retrospectively from the first dialysis day.

Planned dialysis

The patient's first dialysis is planned if:

  1. His first hemodialysis uses an AV fistula
  2. His first hemodialysis uses a permanent catheter as the patient's permanent access
  3. His first peritoneal dialysis is >6 days after catheter placement.

The patient's first dialysis is unplanned if:

  1. His first hemodialysis uses a temporary catheter
  2. His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.
  3. His first peritoneal dialysis is <7 days after catheter placement.

Renal Diagnoses

  1. Shrunken Kidneys of unknown cause
  2. Glomerulonephritis
  3. Chronic interstitial nephropathy, chronic pyelonephritis and postrenal uremia
  4. Polycystic kidney disease
  5. Hypertensive/atherosclerotic renal disease
  6. Diabetic Nephropathy
  7. Other

Causes of unplanned dialysis

  1. Late referral
  2. Acute uremia
  3. Acute progression of chronic uremia
  4. Doubt about reversibility
  5. Clinical indication despite acceptable biochemistry
  6. Fistula problems
  7. Delayed planning (Controversial. I recommend dialysis planning at the latest when eGFR <15 ml/minute. Please use your own definition).
  8. Patient non-compliance
  9. Patient refused dialysis, but later changed his/her mind

Causes of PD modality

  1. Patient choice
  2. Cardiac insufficiency
  3. HD not possible

Causes of HD Modality

  1. Patient Choice
  2. Physically incapable of peritoneal dialysis (PD)
  3. Mentally incapable of PD
  4. Abdominal problems
  5. Wish for Home HD
  6. PD not considered

Table 1 Center Questionnaire

  1. Author:
  2. Centre Name:
  3. Centre type: University/Non-academic
  4. Approximate population covered:
  5. No. new ESRD patients/year
  6. How many of these
  7. Preemptive transplant (%)?
  8. PD (%)?
  9. HD (%)?
  10. What is the
  11. PD prevalence (no. patients)?
  12. HD prevalence?
  13. How many nephrology specialists?
  14. Does the department have an official policy concerning preferred initial modality:
  15. No
  16. PD first
  17. Home HD first
  18. Other (what?)
  19. Does the department have an official policy concerning when pretransplant investigations should be initiated? If so what? If not, is there unofficial consensus? What?
  20. Does the department have an official policy concerning when dialysis modality choice is made? If so what? If not, is there unofficial consensus? What?
  21. Does the department have an official policy concerning when AV fistulae/grafts are prescribed? If so what? If not, is there unofficial consensus? What?
  22. Does the department have an official policy concerning when peritoneal dialysis catheters are prescribed? If so what? If not, is there unofficial consensus? What?
  23. Does the department have an official policy concerning when chronic dialysis is prescribed? If so what? If not, is there unofficial consensus? What?

Table 2. Motivation Questionnaire

You have just prescribed this patient's first dialysis. If you do not believe that the patient's dialysis requirement is chronic, you do not have to fill in this form Put a "1" besides the primary reason for starting dialysis today. Put a "2" besides a (possible) secondary reason for starting dialysis today. Put a "X" besides any other reasons that have been important in influencing your decision to prescribe dialysis today.

Taste disturbances Pulmonary stasis Social (what?) Dyspnea Practical (what?) (e.g. catheter protection) Hypertension Pericarditis Oedema Biochemical Cardiac symptoms High Plasma-Creatinine Fatigue High Urea Anorexia Low glomerular filtration rate (GFR) Nausea/vomiting High Potassium Cachexia/weight loss Acidosis Itching Low calcium Insomnia High Calcium Depression High Phosphate Diarrhea Falling GFR Other (what?)

Table 4. Physician Questionnaire What is your age? What is your sex? Are you a nephrology specialist? How many years have you been a doctor? How many years have you been a nephrology specialist?

Being tested
No intervention
Medical subject headings
Kidney Failure, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients who start planned dialysis initiation as defined by the protocol

    Planned dialysis

    The patient's first dialysis is planned if:

    1. His first hemodialysis uses an AV fistula
    2. His first hemodialysis uses a permanent catheter as the patient's permanent access
    3. His first peritoneal dialysis is >6 days after catheter placement.

    The patient's first dialysis is unplanned if:

    1. His first hemodialysis uses a temporary catheter
    2. His first hemodialysis uses a permanent catheter as the patient's temporary access (i.e. a later AV fistula is planned.
    3. His first peritoneal dialysis is <7 days after catheter placement.

    Measured: 1 year

Secondary outcomes (3)
  1. Death

    Time to patient death

    Measured: 1 year

  2. Choice of dialysis modality

    Centre HD, Home HD, CAPD or APD

    Measured: 1 year

  3. Choice of dialysis access

    AVF, AVG, Temporary CVC, Tunneled CVC, or PD catheter

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2015 (estimated)
  2. Study startJan 2015
  3. Primary completionJan 2019 (estimated)
  4. Study completionJan 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,400 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT02488200
Sponsor's protocol ID
CRU ID 15002474
Acronym
Peridialysis
Status last verified
Feb 2018
First submitted
13 Jun 2015
Last updated
26 Feb 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of End Stage Renal Disease, run by Herlev Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact James G Heaf, MD DMSc (+4535125361, heaf@dadlnet.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients who start planned dialysis initiation as defined by the protocol (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in